BIOMIN TECHNOLOGIES LIMITED – Trademark Portfolio
Entity Type: 24
BIOMIN TECHNOLOGIES LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BIOMIN. The owner is based in LONDON.
QMB INNOVATION CENTRE, NEW ROAD
LONDON E1 2AX , GB
Showing of trademarks Trademarks
Trademark Classifications
BIOMIN TECHNOLOGIES LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does BIOMIN TECHNOLOGIES LIMITED have?
BIOMIN TECHNOLOGIES LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does BIOMIN TECHNOLOGIES LIMITED file in?
BIOMIN TECHNOLOGIES LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are BIOMIN TECHNOLOGIES LIMITED's most well-known trademarks?
BIOMIN TECHNOLOGIES LIMITED's registered trademark portfolio includes well-known marks such as BIOMIN. These are among 2 currently registered trademarks in the portfolio.
What is BIOMIN TECHNOLOGIES LIMITED's trademark registration success rate?
BIOMIN TECHNOLOGIES LIMITED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.